Table 3.
# | k | Controls | k | Patients | ||||
---|---|---|---|---|---|---|---|---|
1 | 0 | Central | SIRP | ICA | 0 | DMN2 | SM | ICA |
2 | 0 | Central | SM | ICA | 0 | FPOLE | AOD | ICA |
3 | 1 | Targets | AOD | SPM | 1 | V1 | SIRP | ICA |
4 | 1 | Central | AOD | ICA | 3 | Central | AOD | ICA |
5 | 1 | DMN2 | AOD | ICA | 3 | RDLPFC | AOD | ICA |
6 | 10 | V1 | SIRP | ICA | 4 | RDLPFC | SM | ICA |
7 | 13 | V1 | SM | ICA | 4 | Encode | SIRP | SPM |
8 | 13 | V1 | AOD | ICA | 4 | Targets | AOD | SPM |
9 | 14 | Novels | AOD | SPM | 4 | RDLPFC | SIRP | ICA |
10 | 14 | Motor | SM | SPM | 4 | DMN2 | AOD | ICA |